New York Life Trust’s Exelon EXC Stock Holding History

New York Life Trust’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$3K	Sell	136 -2,965	-96%	-$75.6K	0.15%	152
2016 Q4	$79K	Sell	3,101 -530	-15%	-$12.6K	0.38%	104
2016 Q3	$86K	Hold	3,631	–	–	0.42%	91
2016 Q2	$94K	Sell	3,631 -503	-12%	-$12.4K	0.46%	72
2016 Q1	$106K	Sell	4,134 -1,467	-26%	-$32.9K	0.46%	72
2015 Q4	$111K	Sell	5,601 -548	-9%	-$11.1K	0.48%	74
2015 Q3	$130K	Buy	+6,149	New	+$138K	0.58%	52
2015 Q1	–	Sell	-4,701	Closed	-$124K	–	221
2014 Q4	$124K	Buy	4,701 +2,531	+117%	+$64.9K	0.49%	79
2014 Q3	$53K	Buy	2,170 +1,214	+127%	+$28.4K	0.22%	145
2014 Q2	$25K	Buy	+956	New	+$24.4K	0.11%	164

Other funds holding EXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

New York Life Trust's EXC Position: Q1 2017 in Review

New York Life Trust reduced its Exelon (EXC) stake by 96% in Q1 2017, selling an estimated $75.6K and leaving 136 shares worth $3K. The position accounts for 0.15% of the portfolio, ranked #152.

New York Life Trust first reported a position in EXC in Q2 2014 and has held it in 10 quarters since. The position peaked at $130K in Q3 2015. 776 funds tracked by Wall St. Rank hold EXC as of Q1 2017.

New York Life Trust held 136 shares of Exelon worth $3K as of Q1 2017.
New York Life Trust sold 2,965 Exelon shares in Q1 2017, an estimated $75.6K.
Exelon made up 0.15% of New York Life Trust's portfolio in Q1 2017, its #152 holding.
New York Life Trust first reported a position in Exelon in Q2 2014 and has held it in 10 quarters since.
New York Life Trust's Exelon position peaked at $130K in Q3 2015.
776 funds tracked by Wall St. Rank held Exelon as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.